Profound Medical Corp. (PROF) stock
PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.85+0.17 (+2.21%)
Close on Nov 11, 2026Market cap $286.78MP/E –Yield –
Profound Medical operating margin
Operating margin is operating income as a percentage of revenue.
Profound Medical's operating margin for the twelve months ending Sep 30, 2026 was -145.1%. For fiscal 2025 it was -256.3%, against -309.6% the year before. The highest annual figure on record is -256.3% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -256.3% | +53.3 |
| FY2024 | Dec 31, 2024 | -309.6% | +88.4 |
| FY2023 | Dec 31, 2023 | -398.0% | +82.9 |
| FY2022 | Dec 31, 2022 | -480.9% | −40.1 |
| FY2021 | Dec 31, 2021 | -440.7% | −182.5 |
| FY2020 | Dec 31, 2020 | -258.3% | +98.8 |
| FY2019 | Dec 31, 2019 | -357.1% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -79.6% | +89.0 |
| Q2 FY2026 | Jun 30, 2026 | -445.7% | +178.8 |
| Q1 FY2026 | Mar 31, 2026 | -150.3% | +275.7 |
| Q4 FY2025 | Dec 31, 2025 | -123.3% | +76.5 |
| Q3 FY2025 | Sep 30, 2025 | -168.5% | +149.2 |
| Q2 FY2025 | Jun 30, 2025 | -624.4% | −273.2 |
| Q1 FY2025 | Mar 31, 2025 | -426.0% | +121.4 |
| Q4 FY2024 | Dec 31, 2024 | -199.8% | – |
| Q3 FY2024 | Sep 30, 2024 | -317.7% | – |
| Q2 FY2024 | Jun 30, 2024 | -351.2% | – |
| Q1 FY2024 | Mar 31, 2024 | -547.4% | – |
See a number that looks wrong?